Stock Events

Stock Events

Search...

Ligand Pharmaceuticals (LGND) Q4 2023 Earnings

8NovConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

0.62

1.17

1.73

2.28

Details

Expected EPS

0.62

Actual EPS

1.02

Surprise EPS

0.4

Surprise Percent

+64.52%

Description

Ligand Pharmaceuticals (LGND) has reported earnings of 1.02 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.